{
  "orphacode": "79432",
  "disease_name": "Oculocutaneous albinism type 2",
  "socioeconomic_impact_studies": [
    {
      "cost": 0,
      "measure": "Qualitative description of quality of life (WHOQOL-BREF)",
      "label": "Quality of life in patients with oculocutaneous albinism",
      "source": "https://doi.org/10.1590/abd1806-4841.20153498",
      "country": "Brazil",
      "year": "2015"
    },
    {
      "cost": 0,
      "measure": "Qualitative description of financial burden and access challenges",
      "label": "A case for the inclusion of oculocutaneous albinism as a skin-related Neglected Tropical Disease",
      "source": "https://doi.org/10.48327/mtsi.v3i4.2023.434",
      "country": "Sub-Saharan Africa",
      "year": "2023"
    }
  ],
  "score": 3,
  "evidence_level": "Low evidence",
  "justification": "Only qualitative studies describing impairment in quality of life and financial or access challenges were identified; no quantitative cost-of-illness data were available.",
  "metadata": {
    "processing_timestamp": "2025-07-18T19:04:14.325258",
    "run_number": 1,
    "orphacode": "79432"
  }
}